Medtronic (MDT) FY2025 10-K Annual Report
Medtronic (MDT) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Jun 20, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Medtronic FY2025 10-K Analysis
Business Overview
- • Core business model: Medical device development, manufacturing, and global distribution focusing on innovation and regulatory compliance
- • Emphasis on cybersecurity and AI risk management, addressing vulnerabilities and regulatory challenges for AI system integration
- • Strategic focus on sustainability with ambitious targets, including net carbon neutral operations by 2030 and net zero emissions by 2045
- • Exposure to evolving global tax regimes, including implementation of OECD Pillar Two Model Rules from fiscal 2025 impacting tax liabilities
- • Ongoing U.S. tax litigation involving Puerto Rico income allocation with potential material adverse financial impact if resolved unfavorably
Management Discussion & Analysis
- • Revenue $33.0B, up 5.0% YoY from $31.4B in fiscal year 2024
- • Operating margin 24.1% vs 23.3% in prior year
- • Best performing segment: Cardiac Rhythm & Heart Failure $11.4B, up 7% YoY
- • Worst performing segment: Restorative Therapies $7.0B, down 2% YoY
- • Operating cash flow $6.5B; $1.2B in share repurchases, $1.0B dividends, $1.8B capital expenditures
- • Management expects low single-digit revenue growth in fiscal 2026; supply chain constraints remain key risk
Risk Factors
- • Cybersecurity risk via IT system breaches threatening global supply chain, customer and payor data integrity
- • CISO with 29 years experience leads cybersecurity risk management, reporting to CIO connected to Executive Committee
- • Board’s Quality Committee directly oversees cybersecurity strategies, ensuring control and unauthorized access prevention
- • Regular Audit Committee briefings on IT security risks with escalation protocols for critical cybersecurity events
Medtronic FY2025 Key Financial MetricsXBRL
Revenue
$33.5B
▲ +3.6% YoY
Net Income
$4.7B
▲ +26.8% YoY
Operating Margin
17.8%
▲ +186bp YoY
Net Margin
13.9%
▲ +254bp YoY
ROE
9.7%
▲ +239bp YoY
Total Assets
$91.7B
▲ +1.9% YoY
EPS (Diluted)
$3.61
▲ +30.8% YoY
Operating Cash Flow
$7.0B
▲ +3.8% YoY
Source: XBRL data from Medtronic FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Medtronic
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.